< Back to search
Filter
1

Zevalin With Non Myeloablative Allogeneic Stem Cell Transplantation in Patients With Non Hodgkin Lymphoma

for
Non-Hodgkins Lymphoma
Location: Montreal
Sponsor: Maisonneuve-Rosemont Hospital

Sex: All

Age: 18 - 65

Code: NCT00807196

Phase1, Phase2, Recruiting

Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective Study

for
Cutaneous T-Cell Lymphoma
Location: Montreal
Sponsor: McGill University

Sex: All

Age: 18+

Code: NCT00779896

Phase1, Phase2, Recruiting

Tafasitamab, Lenalidomide and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

for
Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma
Location: Rochester MN
Sponsor: Academic and Community Cancer Research United

Sex: All

Age: 18+

Code: NCT05910801

Phase2, Recruiting

Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis

for
Lymphomatoid Papulosis, Mycosis Fungoides
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06207812

Recruiting

A Study of BI-1206 in Combination With Rituximab With or Without Acalabrutinib in Subjects With Indolent B-Cell NHL

for
Indolent B-Cell Non-Hodgkin Lymphoma
Location: Louisville KY
Sponsor: BioInvent International AB

Sex: All

Age: 18+

Code: NCT03571568

Phase1, Phase2, Recruiting

Interested in new lymphoma trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Patients With Relapsed/Refractory Follicular Lymphoma Treated With Liso-cel (Lisocabtagene Maraleucel) in the Post Marketing Setting

for
Follicular Lymphoma
Location: Milwaukee WI
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Sex: All

Age: 18+

Code: NCT06794268

Recruiting

Study to Evaluate an Oxaliplatin-based Chemotherapy in Patients With Resistant or Relapsing Non-Hodgkin Lymphoma.

for
Non-Hodgkin Lymphoma
Location: Quebec, Sherbrooke
Sponsor: Centre de recherche du Centre hospitalier universitaire de Sherbrooke

Sex: All

Age: 18+

Code: NCT01019863

Phase2, Recruiting

A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma

for
Advanced Solid Tumor, Cutaneous T-cell Lymphoma (CTCL)
Location: Huntersville NC
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.

Sex: All

Age: 18+

Code: NCT05569057

Phase1, Recruiting

Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab

for
Leukemia/Lymphoma, Cutaneous T Cell Lymphoma, ATLL
Location: Milwaukee WI
Sponsor: Kyowa Kirin, Inc.

Sex: All

Age: 18+

Code: NCT04014374

Recruiting

Open-label Pilot Study of Lenalidomide (Revlimid) as Adjuvant Treatment for Refractory Cutaneous T Cell Lymphoma

for
Cutaneous T Cell Lymphoma
Location: Miami FL
Sponsor: Florida Academic Dermatology Centers

Sex: All

Age: 18+

Code: NCT01132989

Phase2, Recruiting

Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients

for
Mycosis Fungoides, Lymphomatoid Papulosis, Sezary Syndrome
Location: Commack NY, Uniondale NY, East White Plains NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT03587844

Phase2, Recruiting

Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy

for
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified,
Location: Salt Lake City UT
Sponsor: Academic and Community Cancer Research United

Sex: All

Age: 18+

Code: NCT06238648

Phase2, Recruiting

A Phase II Trial of Intermediate Radiation Dose For Lymphoma

for
Follicular Lymphoma
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre

Sex: All

Age: 18+

Code: NCT05284825

Recruiting

Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL

for
Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia,
Location: Columbus OH, Cincinnati OH, Goshen IN, Dallas TX
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT04502394

Phase1, Phase2, Recruiting

Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas

for
Nasopharyngeal Carcinoma, Castrate Resistant Prostate Cancer,
Location: Springdale AR
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT05415098

Phase1, Recruiting

A Study of Rituximab Versus Iodine I 131 Tositumomab Therapy for Patients With Non-Hodgkin's Lymphoma

for
Non-Hodgkin's Lymphoma
Location: Atlanta GA, Walla Walla WA
Sponsor: Corixa Corporation

Sex: All

Age: 18+

Code: NCT00078598

Phase3, Recruiting

Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients

for
Non-Hodgkin's Lymphoma
Location: Boston MA, New Brunswick NJ, Baltimore MD, Bethesda MD,
Sponsor: Xcyte Therapies

Sex: All

Age: 18+

Code: NCT00081783

Phase2, Recruiting

Host Dendritic Cells in Allograft Patients

for
Relapsed Non-Hodgkin's Lymphoma, Hodgkin's Disease,
Location: New York NY
Sponsor: Icahn School of Medicine at Mount Sinai

Sex: All

Age: 18 - 70

Code: NCT00935597

Phase1, Recruiting

Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia

for
B-Cell Lymphoma, B Acute Lymphoblastic Leukemia,
Location: Pittsburgh PA
Sponsor: John Lister

Sex: All

Age: 18 - 70+

Code: NCT05281809

Phase2, Recruiting

A Phase II Study of Linperlisib (YY-20394) in Patients With Relapsed or Refractory Peripheral T/NK Cell Lymphoma

for
Peripheral T/NK Cell Lymphoma (R/R PTCL)
Location: Houston TX
Sponsor: Shanghai YingLi Pharmaceutical Co. Ltd.

Sex: All

Age: 18+

Code: NCT05274997

Phase2, Recruiting